PIK3CA and breast cancer: A blinded set of 25 breast cancer patient FFPE tissue biopsy samples was tested using our in-house triplex dPCR assays without enrichment to detect PIK3CA mutations in exon 9 (E542K, E545K) and exon 20 (H1047L, H1047R) (Fig. 4A).